Immunotherapy is offering new hope for cancers that once had grim prognoses by harnessing the body's own immune system to ...

TONIGHT AND STUNNING RESULTS. AND WE’RE NOT OVERUSING THAT TERM FROM A CLINICAL TRIAL FOR CANCER RESEARCHERS RELYING ON IMMUNOTHERAPY EXCLUSIVELY TO TREAT A SPECIFIC TYPE OF SOLID TUMOR IN DIFFERENT ...

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...

Kelly Spill didn’t cry when she was diagnosed with stage III rectal cancer at age 28. She held her emotions together when her surgeon told her that she might not be able to carry another baby — ...

Healthcare professionals may use immunotherapy as part of the treatment for someone with Hodgkin’s lymphoma. They may also use it as part of palliative therapy to improve a person’s quality of life ...

Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer—the leading cause of cancer deaths worldwide—improved long-term survival overall compared with ...

The global immunotherapy drugs market is expected to grow from $260.7 billion in 2025 and is projected to reach $467.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% ...

Cancer survival might depend on what time of day you get your treatment, a new study says. Lung cancer patients who received IV immunotherapy doses earlier in the day tended to live longer, ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." This story is part of a series on 10 life-saving medical breakthroughs. Click here to read the rest.